Introduction {#S0001}
============

Ischemic cerebrovascular disease is the most common disease in neurology and its prevalence, disability, and mortality are very high.[@CIT0001] The main treatment is to dredge the blocked blood vessels and improve the blood supply of the blocked parts.[@CIT0002] However, when the blood supply to the ischemic site is improved.[@CIT0003] Cerebral ischemia/reperfusion (I/R) injury is a complex pathological and physiological process involving multiple mechanisms.[@CIT0004] The initiating factor of I/R is ischemia and hypoxia. Under reperfusion, brain cells undergo multiple processes, such as the increase of oxygen free radicals, calcium overload, inflammation, excitatory amino acid toxicity, apoptotic gene activation, and so on.[@CIT0005] The induction and regulation of apoptosis is complex, and this process involves a series of apoptosis-related factors and signal transduction pathways.[@CIT0006],[@CIT0007] Therefore, it is important to reveal the mechanisms of neuronal apoptosis and reduce the apoptosis of neurons after cerebral I/R.

Acute brain damage in the brain is caused by central necrosis, while secondary or late death is mainly caused by neuronal apoptosis in the ischemic penumbra.[@CIT0008],[@CIT0009] The progression of apoptosis involves the regulation, expression, and activation of a series of genes.[@CIT0010] Current understandings of the molecular mechanism of apoptosis in cerebral I/R injury are that after the ischemia and hypoxia of the cerebral nerve cells, the energy metabolism of the cells is impaired, and various apoptotic stimulator free radicals, nitric oxide, excitatory amino acid toxicity and calcium overload factors are produced.[@CIT0011],[@CIT0012] The PI3K/Akt signaling pathway plays important roles in promoting cell survival. This signal transduction pathway is involved in the regulation of cell growth, proliferation and differentiation.[@CIT0013] In cerebral ischemia, the PI3K/Akt signaling pathway is a critical signaling pathway that promotes the survival of ischemic nerve cells.[@CIT0014] Therefore, the search for effective PI3K/Akt activators may be a future research direction for the treatment of ischemic cerebrovascular disease.

*Schima wallichii* Korth is a traditional Chinese medicine with important application values.[@CIT0015] Studies have revealed different pharmacological effects of different chemical constituents of *Schima wallichii* Korth, which have different therapeutic or auxiliary therapeutic effects on different diseases.[@CIT0016] Novel chemical composition and new pharmacological effects of *Schima wallichii* Korth are constantly being discovered.[@CIT0017] Studies have found that the leaves of *Schima wallichii* Korth contain active ingredients such as flavonoids, proteins, polysaccharides, lignans and volatile oils.[@CIT0016],[@CIT0018] *Schima wallichii* Korth leaves can play a better role in the treatment of tumors, liver diseases, cerebrovascular diseases, etc.[@CIT0019] Kaempferol-3-O-rhamnoside (K-3-rh) is an active ingredient extracted from *Schima wallichii* Korth leaves.[@CIT0020] It has many biological functions such as antihypertensive, anti-fatigue and anti-tumor effects.[@CIT0021] In recent years, its regulation of antagonizing excitatory neurotransmitters, anti-oxidative damage, and secretion of neuroprotective factors during neurological damage has received increasing attention.[@CIT0022] The chemical structure of K-3-rh is shown in [Figure 1A](#F0001){ref-type="fig"}. However, there are no reports about its effects on cerebral I/R injury. This study was carried out using the animal model of cerebral I/R to investigate whether K-3-rh can inhibit apoptosis by activating the expression of PI3K/Akt signaling pathway, and the pharmacological mechanism of cerebrovascular diseases was explored. It would provide new research directions for finding new drugs for the treatment of cerebral I/R injury.Figure 1(**A**) Chemical structure of K-3-rh. (**B**) Experimental design.

Methods and Materials {#S0002}
=====================

Experimental Animals {#S0002-S2001}
--------------------

Healthy male Sprague-Dawley rats that were 7--8 weeks old and weighing 200 −220 g were provided by the Experimental Animal Center of the affiliated Hospital of Qingdao University. They had free access to drinking water at room temperature 20 −25 °C. All experiments were approved by the affiliated Hospital of Qingdao University Animal Care and Use Committee and conducted in accordance with the National Institutes of Health Laboratory Animal Care and Use Guidelines.

Focal Cerebral Ischemia/Reperfusion (I/R) Model {#S0002-S2002}
-----------------------------------------------

Transient focal ischemia was induced in rats by right middle cerebral artery (MCA) occlusion (MCAO). Briefly, the rats were anesthetized by inhalation of a 69%/30% (vol/vol) mixture of nitrous oxide/oxygen and 1% halothane using a face mask. A midline neck incision was made and the right common carotid artery was exposed. The right MCA was occluded by insertion of 4--0 surgical nylon thread with a silicone coating through the common carotid artery. Using this technique, the tip of the thread occludes the origin of the right MCA. Successful stroke was achieved in nearly all animals. During these procedures, body temperature of rats was monitored with a rectal probe and was maintained at 37 ± 0.3 °C using a heating pad. The surgical incision was then closed and the animals were allowed to recover at room temperature. After 90 min of transient MCA occlusion (tMCAO), the suture was removed to restore blood flow (reperfusion). Sham control animals were treated with cervical surgery but without insertion of the nylon thread. The animals were kept at ambient temperature until sampling, with free access to water and food.[@CIT0023]

Groups and Drug Administration {#S0002-S2003}
------------------------------

Rats were randomly divided into sham-operated group, I/R group, kaempferol-3-O-rhamnoside group, wortmannin group, and K-3-rh + wortmannin group. In the sham group (n = 60), rats were treated with middle cerebral artery occlusion (MCAO), except for non-inserted CCA. In the I/R group (n = 6), reperfusion was performed at 2 h after cerebral ischemia for 24 h in rats. In the kaempferol-3-O-rhamnoside (K-3-rh) group (n = 6), 5--80 mg/kg K-3-rh (Sigma, purity ≥98%) was dissolved in 0.9% NaCl and injected slowly in the rat peritoneum at 2 h after cerebral ischemia. In the wortmannin group (n = 6), it was slowly injected intraperitoneally in rats for 24 h.[@CIT0024] In the K-3-rh (80 mg/kg) + wortmannin (100 nM) group (n = 6), the method was the same as K-3-rh and wortmannin group. The sham group and the I/R group received an equal 0.9% NaCl at the same time. Experimental design is shown in [Figure 1B](#F0001){ref-type="fig"}.

Assessment of Infarct Volume, Neurological Deficit, and Brain Water Content {#S0002-S2004}
---------------------------------------------------------------------------

Rats were cerebral ischemia-reperfusion injury for 24 h, decapitated and removed the olfactory bulb after being quickly frozen. The cerebellum and the lower brainstem were sliced and placed in TTC dye. The staining result in white was for infarction and red was for a normal brain. An image analysis system was used to detect the cerebral infarction volume to the total brain volume.

After 24 h of cerebral I/R in rats, neurological deficits were evaluated by an observer blinded to the treatment of animals (n = 6) after 24 h reperfusion according to the methods previously described: 0 point, rats behave normally; 1 point, rats cannot fully stretch their left front legs; 2 points, rats turn around into a circle; 3 points, rats fall down to the left side; 4 points, rats cannot move by themselves and lose their consciousness.[@CIT0025]

After 24 h of cerebral I/R injury, the rats were decapitated. The olfactory bulb, the cerebellum and the lower brainstem were removed, and the wet mass of the brain was weighed. Dry mass was weighed after baking.

TUNEL Staining {#S0002-S2005}
--------------

Cells were stained with TUNEL assay kit (Qianchen, Shanghai, China). The percentage of TUNEL-positive cells was counted by a fluorescence microscopy (Shimei, Shanghai, China).

Apoptosis Was Detected by Flow Cytometry {#S0002-S2006}
----------------------------------------

Enzymatic-mechanic method was used to isolate cells.[@CIT0026] Briefly, the brains of anaesthetized rats were harvested and hippocampi were completely removed on ice quickly. The tissues were rinsed in PBS at 4°C to discharge blood. Then, each hippocampus was transferred into a 1.5 mL centrifuge tube filled with PBS at 4 °C. The tissues were minced with ophthalmic scissors until no large pieces were observed and then centrifuged to remove supernatants. Subsequently, 1 mL pre-warmed 0.25% Trypsin-EDTA was added into the tube to resuspend the tissue masses. After incubation at 37 °C for 15 min, the mixture was filtered through a cell strainer, and the filtrate was centrifuged at 300× g for 5 min to remove supernatants. The precipitations were gently washed with precooled PBS twice and resuspended in 1 mL PBS. The cell quantities of all samples were counted. The suspensions were labeled with Annexin V-FITC and PI according to the protocol and analyzed by FCM.

Real-Time Quantitative RT-PCR {#S0002-S2007}
-----------------------------

Total RNAs in cells were extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). The qRT-PCR reactions were performed using a ViiA^TM^ 7 real-time PCR system (Jinuo, Shanghai, China). GAPDH and U6 were used as internal references. The expression levels of P53 were detected using SYBR Premix Ex Taq II (Takara Biotechnology). The specific experimental methods of qRT-PCR were performed with reference to the literature.[@CIT0027] Primer sequences are listed in [Table 1](#T0001){ref-type="table"}.Table 1Sequences of Primers Used in RT-qPCRGeneForward Primer (5ʹ-3ʹ)Reversed Primer (5ʹ-3ʹ)*P53*TCCAGTTCATTGGGACTTATCCTTGGCTCATATCCGACTGTGAATCCTC*Bcl-2*GACGGAGTACCTGAACCGGCTTCCGGAGCAGCGTCTTCAGAGCCA*Bax*TGGCGATGAACTGGACACCAAGGGAGTCTGTATCCACTTCAACA*β-actin*GCAGGAATACGTTGAGTCCGACGCAGCTCAGTTACAGTTC

Western Blot Analysis {#S0002-S2008}
---------------------

The right hippocampus and cortical tissues were quickly extracted on ice and weighed. The cortex was ground and then weighed to get about 80 mg homogenate. The brain tissue was weighed in a fine balance, and total proteins were extracted. The protein concentration was quantified by the BCA Protein Assay Kit and transferred to the PVDF membrane by electrophoresis. The membrane was incubated with rabbit anti-Bcl-2 (1:1000), Bax (1:1000), p-Akt (Ser 473) (1:500), Akt (1:500) and β-actin (1:1000, Santa Cruz Biotechnology) for overnight, followed by incubation with 1:5000 labeled anti-rabbit secondary antibody for 1 h. Western blot analysis was performed as described in the literature.[@CIT0028]

Statistical Analysis {#S0002-S2009}
--------------------

Data were analyzed by SPSS19.0 statistical software. The results were shown as mean ± standard deviation (mean ± SD). Multigroup comparisons were conducted based on one-way ANOVA. LSD test was used for subsequent analysis. *P* \< 0.05 was considered as significant difference.

Results {#S0003}
=======

K-3-Rh Decreased the Infarct Volumes, Behavioral Outcomes and Water Content {#S0003-S2001}
---------------------------------------------------------------------------

To assess the effect of K-3-rh on brain I/R injury in the I/R rat model, rats were treated with different doses of K-3-rh (5--80 mg/kg). As shown in [Figure 2A](#F0002){ref-type="fig"}, compared to the Sham group, the neurological deficit score in the I/R group was significantly increased (*P* \< 0.05). Compared to the I/R group, the neurological deficit scores were significantly decreased in the K-3-rh group (*P* \< 0.05, *P* \< 0.01). The infarct size of the I/R group was significantly increased compared to that in the Sham group (*P* \< 0.01), and the infarct size of the rats in the K-3-rh group was significantly increased compared to that in the I/R group (*P* \< 0.05, *P* \<0.01) ([Figure 2B](#F0002){ref-type="fig"} and [C](#F0002){ref-type="fig"}). As shown in [Figure 2D](#F0002){ref-type="fig"}, compared to the Sham group, the brain water content in the I/R group was significantly increased (*P* \< 0.05). The brain water content in the K-3-rh group was significantly reduced compared to that in the I/R group (*P* \< 0.05, *P* \< 0.01). These findings demonstrated the effectiveness of K-3-rh on brain I/R injury.Figure 2Effect of (**A**) K-3-rh on neurobehavioral behavior. (**B, C**) Effect of K-3-rh on infarct volume. (**D**) Effect of K-3-rh on brain water content. VS, \#\#*P* \< 0.01; VS the I/R group, \**P* \< 0.05, \*\**P* \< 0.01.

K-3-Rh Attenuated I/R Injury Induced Apoptosis {#S0003-S2002}
----------------------------------------------

As shown in [Figure 3](#F0003){ref-type="fig"}, the apoptotic cell rate of the sham group was less than 5%. Compared to the Sham group, the apoptosis rate of I/R group was as high as (41.05 ± 3.18)%, which was significantly increased compared to that in the sham group (*P* \< 0.01). Compared to the I/R group, the proportion of apoptotic cells in the K-3-rh treatment group decreased to (32.33 ± 2.11)%, (27.45 ± 3.03)% and (17.71 ± 1.94)%, respectively, which was significantly lower compared to that in the I/R Group (*P* \< 0.05, *P* \< 0.01). These results indicated that K-3-rh exerted neuroprotective effects on I/R by inducing apoptosis.Figure 3Effect of K-3-rh on apoptosis. VS, \#\#*P* \< 0.01; VS the I/R group, \**P* \< 0.05, \*\**P* \< 0.01.

In addition, as shown in [Figure 4](#F0004){ref-type="fig"}, almost no positive cells were expressed in the brain tissues of the Sham group. In contrast, a large number of TUNEL-positive cells were expressed in the brain I/R injury model group (*P* \< 0.01). The number of TUNEL-positive cells in the ischemic penumbra of the K-3-rh group was significantly reduced compared to that in the I/R model group (*P* \< 0.01). These results indicated that K-3-rh can effectively reduce I/R-induced neuronal death.Figure 4Effect of K-3-rh detected by TUNEL staining on neuronal apoptosis. Scale bar = 50 μm (×400 times). VS, \#\#*P* \< 0.01; VS the I/R group, \**P* \< 0.05, \*\**P* \< 0.01.

Effects of K-3-Rh Treatment on the Expression of Apoptosis-Related Proteins {#S0003-S2003}
---------------------------------------------------------------------------

As shown in [Figure 5A](#F0005){ref-type="fig"} and [B](#F0005){ref-type="fig"}, compared to the sham group, expression levels of p53 in the hippocampus and cortex of the I/R group were significantly increased (*P* \< 0.01). Compared to the I/R group, the expression levels of p53 in the hippocampus and cortex of the K-3-rh-treated group were significantly reduced (*P* \< 0.05, *P* \< 0.01). As shown in [Figures 5C](#F0005){ref-type="fig"}--F and [6](#F0006){ref-type="fig"}, compared to the sham group, the expression of Bcl-2 in hippocampus and cortex of I/R group was significantly down-regulated, and the expression of Bax was significantly up-regulated (*P* \< 0.01) at both mRNA and protein levels. Compared to the I/R group, the expression of Bcl-2 in hippocampus and cortex of K-3-rh treatment group was significantly up-regulated, and the expression of Bax was significantly down-regulated at both mRNA and protein levels (*P* \< 0.05, *P* \< 0.01).Figure 5Effect of K-3-rh on the expression of P53, Bcl-2 and Bax mRNA in hippocampus and cortex after reperfusion. (**A**) In the hippocampus, the mRNA levels of p53. (**B**) In the cortex, the mRNA levels of P53. (**C**) In the hippocampus, the mRNA levels of Bcl-2. (**D**) In the cortex, the mRNA levels of Bcl-2. (**E**) In the hippocampus, the mRNA levels of Bax. (**F**) In the cortex, the mRNA levels of Bax. VS, \#*P* \< 0.05, \#\#*P* \< 0.01; VS the I/R group, \**P* \< 0.05, \*\**P* \< 0.01.Figure 6Effect of K-3-rh on Bcl-2 and Bax in hippocampus and cortex. (**A**) In the hippocampus, the protein levels of Bcl-2 and Bax. (**B**) Relative density of Bcl-2 and β-actin. (**C**) Relative density of Bax and β-actin. (**D**) In the cortex, the protein levels of Bcl-2 and Bax e. (**E**) Relative density of Bcl-2 and β-actin. (**F**) Relative density of Bax and β-actin. VS, \#\#*P* \< 0.01; VS the I/R group, \**P* \< 0.05, \*\**P* \< 0.01.

K-3-Rh Enhanced the Phosphorylation of AKt After Cerebral I/R Injury {#S0003-S2004}
--------------------------------------------------------------------

As shown in [Figure 7A](#F0007){ref-type="fig"} and [B](#F0007){ref-type="fig"}, compared to the I/R group, the cerebral infarct size and brain water content of the K-3-rh group were significantly reduced. Compared to the K-3-rh group, the cerebral infarct size and brain water content of the rats in the K-3-rh + Wortmannin group were significantly raised (*P* \< 0.05, *P* \< 0.01). As shown in [Figure 7C](#F0007){ref-type="fig"}--[F](#F0007){ref-type="fig"}, the expression of p-Akt was significantly increased in the K-3-rh group compared to that in the I/R group. Compared to the K-3-rh group, the expression of p-Akt was significantly inhibited in the K-3-rh + Wortmannin group (*P* \< 0.05, *P* \< 0.01).Figure 7K-3-rh enhanced phosphorylation of AKt following brain I/R injury. (**A**) Changes in infarct volume under different treatment conditions. (**B**) Effects of brain water content under different treatment conditions. (**C**) Expression level of pAkt on Ser473 in the hippocampus. (**D**) Density of p-Akt relative to total hippocampal Akt. (**E**) Expression level of pAkt on Ser473 in the cortex. (**F**) Relative density of p-Akt to total Akt in the cortex. VS the sham operation group, \#\#P \< 0.01; VS the I/R group, \*\*P \< 0.01; VS 80 mg/kg + wortmannin, &&P \< 0.01, &P \< 0.05.

Discussion {#S0004}
==========

Coronary heart disease is one of the major diseases that endanger human health, and acute myocardial infarction is a common type of coronary heart disease.[@CIT0029] With the popularization and implementation of emergency interventional therapy or emergency thrombolysis, patients with myocardial infarction are not only saved, but the prognosis was also improved. However, I/R injury has always been a difficult problem in the treatment of acute myocardial infarction reperfusion. It often causes myocardial cell apoptosis, left ventricular remodeling, arrhythmia and heart failure. Studies have found that myocardial cells have both necrotic and apoptotic forms during I/R in acute myocardial infarction, and apoptosis can be caused by acute myocardial infarction.[@CIT0030],[@CIT0031]

With the induction of external death signals, nucleated cells initiate their own internal gene expression and regulation through signal transduction pathways, leading to programmed process of cell death, which has a great effect on normal embryos and the maintenance of the stability of mature tissues and organs.[@CIT0032] Apoptosis can occur under many pathological conditions. Studies have shown that apoptosis is the main form of myocardial I/R injury and is one of the main factors affecting the effect of myocardial infarction reperfusion.[@CIT0033]

Oxidative stress plays important roles in the pathogenesis of ischemia-reperfusion injury in the brain.[@CIT0034] Studies have shown that the leaves of *Schima wallichii* Korth contain the same active ingredients as in fruits.[@CIT0016] In addition, pharmacological experiments have also shown that the extract of the leaves of *Schima wallichii* Korth has multiple functions such as liver protection, antibacterial and anti-oxidation. K-3-rh is an activity extracted from the leaves of *Schima wallichii* Korth.[@CIT0016] In addition, studies have found that K-3-rh can effectively reduce dimethyl butyric acid-induced oxidative stress, restore antioxidant enzyme activity, and reduce lipid peroxidation.[@CIT0035] Nevertheless, the molecular mechanism of K-3-rh through ischemia-reperfusion injury has not been fully elucidated. In this study, a rat model of cerebral I/R was established to confirm that K-3-rh can alleviate cerebral ischemic neurological damage, cerebral infarction volume, and reduce brain water content. Flow cytometry, TUNEL staining and protein immunoassay showed that K-3-rh was able to reduce the expression levels of Bax in hippocampus and cortex and increase the expression levels of Bcl-2. These results indicated that K-3-rh treatment can inhibit I/R-induced apoptosis and neurons.

Upon cerebral ischemia, activated NF-κB up-regulates many proapoptotic target genes leading to neuronal apoptosis, of which p53 is one of the target genes for NF-κB-mediated neuronal apoptosis.[@CIT0036] P53 is an important gene regulating cell proliferation, which is involved in cell growth and plays an important role in apoptosis.[@CIT0037] In cerebral ischemia, p53 mediates neuronal apoptosis by transcription-dependent and transcription-independent mechanisms, aggravating ischemic brain damage.[@CIT0001] The results in this study showed that the expression of p53 in the brain of mice was significantly up-regulated after cerebral ischemia/reperfusion, and K-3-rh significantly inhibited the expression of p53. Therefore, we hypothesized that K-3-rh may have a neuroprotective effect on I/R by inhibiting the expression of p53 and apoptosis-related factors after cerebral ischemic injury.

The PI3K/Akt signaling pathway can promote cell survival.[@CIT0038] It is a signal transduction pathway involved in cell growth, proliferation, and differentiation regulation.[@CIT0039] At cerebral ischemia, the PI3K/Akt signaling pathway can promote the survival of ischemic nerve cells.[@CIT0040] Short-term ischemic preconditioning can alleviate ischemic brain damage and up-regulate the expression of p-Akt in brain tissues.[@CIT0041] Intraventricular injection of PI3K inhibitor wortmannin can restrain the expression of p-Akt and the neuroprotective effect of ischemic preconditioning, indicating that the PI3K/Akt signaling pathway takes part in the regulation of neuroprotective effects of ischemic preconditioning on cerebral ischemia.[@CIT0042] Our study found that the expression of p-Akt was up-regulated in the K-3-rh group. Compared with K-3-rh group, K-3-rh + Wortmannin significantly inhibited the expression of p-Akt and reversed the effects of K-3-rh on neurological deficit scores and infarct size. Therefore, it inhibited the occurrence of neuronal apoptosis after cerebral ischemia and exerted a neuroprotective effect on I/R rats. It was observed that K-3-rh attenuated nerve damage in rat cerebral ischemia by PI3K/Akt signaling pathway. In future studies, we would try to assess the effects of K-3-rh on cell apoptosis in in vitro studies (OGD/OGD/R model, etc.) and evaluate the effect of K-3-rh on blood--brain barrier systematically in further studies to confirm and expand our findings.

Conclusion {#S0005}
==========

K-3-rh attenuated cerebral I/R injury by activating PI3K/Akt signaling pathway to inhibit apoptosis. And PI3K/Akt signaling pathway may be a new target to treat ischemic cerebrovascular disease in the future.
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